Aster Capital Management (Difc) LTD Gossamer Bio, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $462 Billion
- Q3 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 134,563 shares of GOSS stock, worth $110,341. This represents 0.03% of its overall portfolio holdings.
Number of Shares
134,563Holding current value
$110,341% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding GOSS
# of Institutions
109Shares Held
168MCall Options Held
430KPut Options Held
519K-
Nea Management Company, LLC Timonium, MD18.1MShares$14.8 Million1.37% of portfolio
-
Siren, L.L.C. New York, NY13.3MShares$10.9 Million0.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$9.64 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$7.53 Million2.2% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$6.61 Million4.79% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $77M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...